Advances in computer simulations allow researchers to look at G protein-coupled receptors in more detail than ever before.

FDA to phase out mandatory animal testing with human-relevant methods for drug development

The 2025 Power List will be available soon!

In the highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Donald Trump threatens “major tariff” on pharmaceuticals.

We dive into the archive of 2022 for insight and inspiration – this time with Kowid Ho

Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society.

Job cuts at the FDA spark concern, with Robert Califf saying the agency as we know it is “finished.”

Looking ahead to the next 5–10 years, what will be the key disruptors and/or what can be improved upon in the pharma industry?